Oligonucleotide Ligation Assay (OLA) Resistance Study

NACompletedINTERVENTIONAL
Enrollment

991

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

February 28, 2017

Conditions
HIV Positive
Interventions
OTHER

Pre-ART Oligonucleotide Assay (OLA)

Block randomization (1:1) to pre-ART OLA testing or OLA testing after 12mo on ART

Trial Locations (2)

Unknown

Coptic Hospital, Maseno

Coptic Hospital, Nairobi

All Listed Sponsors
collaborator

Seattle Children's Hospital

OTHER

collaborator

University of Nairobi

OTHER

lead

University of Washington

OTHER

NCT01898754 - Oligonucleotide Ligation Assay (OLA) Resistance Study | Biotech Hunter | Biotech Hunter